⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4532985 | 0.97 | — | — | |
| SCHEMBL25023926 | 0.72 | — | — | |
| SCHEMBL4004854 | 0.72 | — | — | |
| SCHEMBL8765419 | 0.72 | — | — | |
| SCHEMBL19956318 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL3484169 | 0.70 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL4521898 | 0.70 | CA1 (0.37) | — | |
| SCHEMBL6735677 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL9460501 | 0.69 | — | — | |
| SCHEMBL11275226 | 0.67 | ALDH1A1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11913071-B2 | Methods and compositions for sequencing complementary polynucleotides | Singular Genomics Systems, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20240026428-A1 | METHODS FOR IN SITU TRANSCRIPTOMICS AND PROTEOMICS | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-01-25 | — | — | US | disclosed |
| US-20230399692-A1 | NUCLEIC ACID DELIVERY SCAFFOLDS | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-12-14 | — | — | US | disclosed |
| US-20230366013-A1 | SPATIAL SEQUENCING | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-16 | — | — | US | disclosed |
| US-20230357828-A1 | SPATIAL SEQUENCING OF MODIFIED SEQUENCES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-09 | — | — | US | disclosed |
| US-11795505-B2 | Nucleic acid delivery scaffolds | Singular Genomics Systems, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
| US-11788133-B2 | Methods and compositions for sequencing complementary polynucleotides | Singular Genomics Systems, Inc. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230295437-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | Singular Genomics Systems, Inc. | 2023-09-21 | — | — | US | disclosed |
| US-20230287491-A1 | NUCLEIC ACID DELIVERY SCAFFOLDS | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-09-14 | — | — | US | disclosed |
| US-11753678-B2 | Spatial sequencing | Singular Genomics Systems, Inc. (US) | 2023-09-12 | — | — | US | disclosed |
| US-20230160001-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-05-25 | — | — | US | disclosed |
| US-11649452-B2 | High density sequencing and multiplexed priming | Singular Genomics Systems, Inc. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11643679-B2 | Methods for in situ transcriptomics and proteomics | SINGULAR GENOMICS SYTEMS, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-9644195-B2 | Compounds and methods for purification of serine proteases | PORTOLA PHARMACEUTICALS, INC. (US) | 2017-05-09 | — | — | US | disclosed |
| US-9200268-B2 | Compounds and methods for purification of serine proteases | PORTOLA PHARMACEUTICALS, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| US-20150337285-A1 | COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES | ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY (IE) | 2015-11-26 | — | — | US | disclosed |
| US-20150175998-A1 | Methods and Kits to Create Protein Substrate˜HECT-Ubiquitin Ligase Pairs | NORTHWESTERN UNIVERSITY | 2015-06-25 | — | — | US | disclosed |
| US-20140346397-A1 | COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES | ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY (IE) | 2014-11-27 | — | — | US | disclosed |
| US-20140186923-A1 | COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES | PORTOLA PHARMACEUTICALS, INC. (US) | 2014-07-03 | — | — | US | disclosed |
| US-6806380-B2 | SUCH AS 1-METHOXY-2-(3-METHYLPHENYL)ETHANIMINE BY TREATING NITRILE WITH ANHYDROUS HYDROGEN CHLORIDE SOLUTION AND ANHYDROUS ALCOHOL | LEXICON PHARMACEUTICALS, INC. | 2004-10-19 | — | — | US | disclosed |